Drug
Tirapazamine clinical trials
Also written Tirazone and WIN 59075.
- studies test it
- 19
- open now
- 2
- in phase 3
- 6
- first study started
- 1996
Keep track of what changes. Save the Tirapazamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2000 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1998 | 2 |
| 2000 | 4 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 9
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 12
National Cancer Institute (NCI) (4) · Sanofi (3) · SWOG Cancer Research Network (3) · Teclison Ltd. (2) · Zhejiang Raygene Pharmaceuticals Co., Ltd (2) · City of Hope Medical Center (1) · Stanford University (1) · Peter MacCallum Cancer Centre, Australia (1)
Often tested with
Tested in the same studies.
Cisplatin (7) · Carboplatin (3) · Paclitaxel (3) · Etoposide (2) · Vinorelbine (1) · Cyclophosphamide (1) · Vincristine (1) · Irinotecan (1)
Studies
Open first, then newest update. How each study uses Tirapazamine is read from its arms, and is right about nine times in ten.
Testing it · 19
- Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerRecruitingPhase 1/2Teclison Ltd.NCT02174549Written as Tirapazamine
- A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.RecruitingPhase 2/3Zhejiang Raygene Pharmaceuticals Co., LtdNCT06844357Written as tirapazamine
- Evaluate the Effect of Tirazamine on Primary Liver Cancer.TerminatedPhase 1/2Zhejiang Raygene Pharmaceuticals Co., LtdNCT06848556Written as tirapazamine
- TATE Versus TACE in Intermediate Stage HCCTerminatedPhase 2Teclison Ltd.NCT03145558Written as Tirapazamine
- Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical CancerTerminatedPhase 3National Cancer Institute (NCI)NCT00262821Written as tirapazamine
- TRACE: Tirapazamine-Radiation And Cisplatin EvaluationCompletedPhase 3SanofiNCT00174837Written as Tirapazamine
- Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid TumorsCompletedPhase 1City of Hope Medical CenterNCT00005078Written as tirapazamine
- Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedPhase 2Stanford UniversityNCT00002774Written as Tirapazamine
- Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung CancerCompletedPhase 2National Cancer Institute (NCI)NCT00066742Written as tirapazamine
- Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedPhase 3SanofiNCT00017459Written as tirapazamine
- Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedPhase 1Peter MacCallum Cancer Centre, AustraliaNCT00098995Written as tirapazamine
- Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedPhase 3SWOG Cancer Research NetworkNCT00006484Written as tirapazamine
- Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT00003288Written as tirapazamine
- Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaCompletedPhase 2National Cancer Institute (NCI)NCT00025363Written as tirapazamine
- S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung CancerCompletedPhase 1SWOG Cancer Research NetworkNCT00006487Written as tirapazamine
- S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical CancerCompletedPhase 2SWOG Cancer Research NetworkNCT00003369Written as tirapazamine
- Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedPhase 2Gynecologic Oncology GroupNCT00020696Written as tirapazamine
- Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerCompletedPhase 3SanofiNCT00094081Written as tirapazamine (SR259075)
- Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedPhase 1California Cancer ConsortiumNCT00033410Written as tirapazamine
Codes
What other systems call Tirapazamine · ClinicalTrials.gg INT006785
- MeSH (NLM) D000077704TirapazamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1UD32YR59GTIRAPAZAMINEConfirmed FDA, NLM, Wikidata
- Wikidata Q3529346tirapazamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1464TirapazamineOne source FDA
- DrugBank DB04858One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077704 | Tirapazamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1UD32YR59G | TIRAPAZAMINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3529346 | tirapazamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1464 | Tirapazamine | One source FDA |
| DrugBank | DB04858 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.